Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Weather forecast, Turkana style: A goat's intestines tell it all - 2I thought I knew the night sky, but what I saw from the Canary Islands left me speechless
- 3Pleasant Cycle Courses All over the Planet
- 4Hundreds rally in West Bank against Israeli death penalty for Palestinians
- 5Paris Agreement target off the table, report says
- Living in the dark: Gaza’s struggle for electricity
- Vice President Dick Cheney’s life followed the arc of the biggest breakthroughs in cardiovascular medicine
- NASA is shooting for the moon. A guide to the Artemis II mission
- Explainer-Why are hepatitis B vaccines given to newborns?
- 10 High priority Contraptions for Tech Aficionados
- MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
- Anger as German family business group opens talks with far-right AfD
- Doctors seek to understand why quitting antidepressants causes withdrawal for some
- Find Exemplary Scents: An Extensive Aide
